EntryPoint Capital’s Mineralys Therapeutics MLYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-12,487
| Closed | -$154K | – | 849 |
|
|
2024
Q4 | $154K | Buy |
+12,487
| New | +$154K | 0.06% | 631 |
|
|
2024
Q3 | – | Sell |
-7,956
| Closed | -$93.1K | – | 937 |
|
|
2024
Q2 | $93.1K | Buy |
7,956
+3,324
| +72% | +$38.9K | 0.14% | 342 |
|
|
2024
Q1 | $59.8K | Sell |
4,632
-2,020
| -30% | -$26.1K | 0.05% | 669 |
|
|
2023
Q4 | $57.2K | Buy |
+6,652
| New | +$57.2K | 0.05% | 655 |
|